Pentobarbital Sodium

CHEMBL971 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

248.2 g/mol

LogP

—

Phase

4

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Peso Molecular

248,2500 g/mol

TPSA

81,60 Å²

Áreas Terapêuticas

Neurology Epilepsy

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.[Na+]

InChI

InChI=1S/C11H18N2O3.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1

Molecular Formula

C11H17N2NaO3

HBD / HBA

1 / 3

Ligações Rotacionáveis

4

Átomos Pesados

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Yes, Pentobarbital Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL971. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23676152. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Pentobarbital Sodium no PillFYI

Estrutura

Dados Rápidos

Fórmula: C11H17N2NaO3
Sinônimos: 3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.